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ABSTRACT
Left ventricular assist devices (LVADs) are surgically implanted mechanical pumps that improve 
survival rates for individuals with advanced heart failure. While life-saving, LVAD therapy is also 
associated with high morbidity, which can be partially attributed to the difficulties in identifying an 
LVAD complication before an adverse event occurs. Methods that are currently used to monitor for 
complications in LVAD-supported individuals require frequent clinical assessments at specialized 
LVAD centers. Remote analysis of digitally recorded precordial sounds has the potential to provide an 
inexpensive point-of-care diagnostic tool to assess both device function and the degree of cardiac support 
in LVAD recipients, facilitating real-time, remote monitoring for early detection of complications. To 
our knowledge, prior studies of precordial sounds in LVAD-supported individuals have analyzed LVAD 
noise rather than intrinsic heart sounds, due to a focus on detecting pump complications, and perhaps the 
obscuring of heart sounds by LVAD noise. In this letter, we describe an adaptive filtering method to 
remove sounds generated by the LVAD, making it possible to automatically isolate and analyze 
underlying heart sounds. We present preliminary results describing acoustic signatures of heart sounds 
extracted from in vivo data obtained from LVAD-supported individuals. These findings are significant 
as they provide proof-of-concept evidence for further exploration of heart sound analysis in LVAD-
supported individuals to identify cardiac abnormalities and changes in LVAD support. 
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INTRODUCTION 
In cases of advanced heart failure (HF), a left 
ventricular assist device (LVAD) may be 
implanted to assist heart function, rerouting blood 
from the left ventricle of the heart into the aorta via 
a mechanical pump. While conferring a survival 
benefit, LVAD therapy is also characterized by a 
high complication rate, with hospital readmission 
rates of 31% within one month [1] and up to 80% 
within one year of LVAD implantation [2-4]. 
Common complications include infection, 
gastrointestinal bleeding, right heart failure, 
stroke, and formation of blood clots within the 
LVAD (or thrombosis) [5]. Due to the high 
complication rate associated with LVAD therapy, 
the clinical management of LVAD-supported 
individuals involves routine clinic visits to assess 
patient health. Despite this, many LVAD 
complications are not detected until they are at an 
advanced stage, when patients present with severe 
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or life-threatening symptoms, resulting in 
prolonged hospital stays and the need to pursue 
high risk rescue strategies. 
Frequent visits to specialized LVAD centers 
can be costly.  Furthermore, without overt 
evidence for device malfunction, impending 
complications may not be readily apparent. 
Remote monitoring of LVAD-supported 
individuals could allow physicians to identify 
complications that arise between clinic visits and 
initiate treatment to mitigate impending 
complications. Thus, there is a critical need for 
point-of-care diagnostic tools that can be deployed 
in patients’ homes to facilitate remote surveillance 
and early identification of LVAD complications. 
Running pumps, including the heart and 
LVAD, generate sounds with characteristic  
frequency spectra based on pump structure, speed 
and loading conditions [6-8]. Changes in the 
distribution of spectral energy can be analyzed to 
assess proper function [8-10]. Auscultation, 
performed by listening to physiological sounds 
with a stethoscope, is an inexpensive and quick 
method used by physicians to diagnose various 
cardiovascular problems. For example, 
cardiologists assess psychoacoustic features, such 
as loudness, pitch, and tonality, to identify valvular 
heart disease [11-13]. However, the dominance of 
the LVAD sounds in the acoustic frequency 
spectrum limits the use of auscultation in LVAD-
supported individuals. Advances in digital 
stethoscopes have allowed for high-fidelity digital 
sound recordings, making acoustic analysis a 
potential non-invasive remote monitoring 
approach that could be used to identify LVAD 
complications between clinical visits. Previous 
studies have shown differences in the acoustic 
frequency spectra of LVADs with and without 
thrombi [14-17], demonstrating the potential 
diagnostic utility of acoustic analysis in LVAD-
supported individuals.  
While prior acoustic analysis in LVAD-
supported individuals has focused on assessing 
LVAD function, we focus on the analysis of 
underlying heart sounds that are normally 
obscured by LVAD sounds. We leverage adaptive 
filtering and knowledge of LVAD and heart sound 
characteristics to develop an algorithm to extract 
heart sounds in the presence of the LVAD sounds. 
Using data obtained in vivo from LVAD-supported 
individuals, we demonstrate that the filtering of 
LVAD sounds can isolate heart sounds. After 
application of a state-of-the art heart sound 
segmentation algorithm [18] to the denoised 
signals, we analyze their acoustic signatures with 
reference to known heart sound characteristics 
using various time and frequency domain 
representations with the goal of extracting heart 
sounds.  
 
BACKGROUND 
Auscultation of heart sounds is performed by 
listening to sounds through the chest wall 
overlaying the heart, known as the precordium, 
with a stethoscope; sounds recorded from this 
region will be referred to as precordial sounds. 
Precordial sounds may contain a mixture of 
physiological signals, predominantly heart and 
breath sounds, each of which have distinctive 
time-frequency characteristics [19]. A recording of 
heart sounds is known as a phonocardiogram 
(PCG). 
In automatic heart sound segmentation, the 
cardiac cycle is split into four stages: the first heart 
sound or S1 (closure of atrioventricular valves), 
systole (heart muscle contraction), the second 
heart sound or S2 (closure of semi-lunar valves), 
and diastole (heart muscle relaxation) [11, 18, 20, 
21]. Here, S1 and S2 will be referred to as the 
fundamental heart sounds (FHSs), and systole and 
diastole will be referred to as the inter-FHS 
regions. The FHSs are generally expected to be the 
loudest sounds occurring in a PCG signal, and 
exhibit distinct frequency characteristics [11, 21, 
22]. The majority of the energy in S1 and S2 is 
concentrated below 150 Hz, with S2 (24-144 Hz) 
having a wider frequency range than S1 (24-104 
Hz) [22, 23]. It is important to note that the inter-
FHS regions may contain extra heart sounds (S3 
and S4) and murmurs (due to stenosis, 
regurgitation, etc.) that may be indicative of 
additional pathology  [11]. 
In LVAD-supported individuals, precordial 
sounds contain a mixture of physiological and 
LVAD sounds. The frequency characteristics of 
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LVAD sounds are determined by the pump’s 
rotational frequency, structure and loading 
conditions. FHSs, by contrast, are determined 
primarily by cardiac loading conditions. For 
example, S2 predominantly reflects aortic valve 
closure that occurs when the aortic pressure 
exceeds left ventricular pressure. Because the 
LVAD lowers left ventricular pressure, many 
LVAD recipients will have an aortic valve that is 
mostly closed and have an absent or diminished 
S2. By contrast, patients with ineffective LVAD 
unloading have higher left ventricular pressures 
and may have more aortic valve opening and 
closing, manifesting as a more prominent S2. 
Thus, longitudinal changes in intrinsic heart 
sounds may be useful to monitor for changes in 
LVAD support and an impending complication of 
LVAD therapy. 
 
METHODS 
The typical framework for heart sound analysis 
includes signal pre-processing to increase the 
signal-to-noise ratio (SNR) of underlying heart 
sounds, segmentation into cardiac cycle stages, 
and feature extraction for further analysis [24-26]. 
In this study, it is assumed that the precordial 
sounds recorded from the two subjects that 
participated in the study primarily consist of 
LVAD and heart sounds. After pre-processing, 
intrinsic precordial sounds and LVAD sounds are 
separated prior to cardiac cycle segmentation. 
Signal processing and analysis were performed in 
MATLAB© (The MathWorks, Inc.). 
A.  Data Description 
 The data were collected from two patients 
followed by the Duke Mechanical Circulatory 
Support Program at Duke University Hospital; this 
work was approved by the Duke Health 
Institutional Review Board [27]. Both patients, 
hereafter referred to as Subject A and Subject B, 
underwent a medical intervention after an LVAD 
complication. Pre- and post-intervention, 
recordings of precordial sounds were obtained by 
a physician from each patient’s left upper sternal 
border using a Thinklabs digital stethoscope 
(Thinklabs Medical LLC, Centennial, CO). During 
playback of the recordings, heart sounds, LVAD 
noise, and to a lesser extent, breath sounds, were 
observed, with breath sounds being more 
pronounced in Subject A’s recordings. 
Each subject’s LVAD model, pump operating 
speed and rotor parameters were noted and used to 
characterize the acoustic frequency spectrum of 
their LVAD. Subject A was implanted with a 
HeartMate II LVAD (HMII; Thoratec 
Corporation, Inc., Pleasanton, CA) and underwent 
a surgical pump exchange for pump thrombosis. 
The HMII is an axial-flow pump with three rotor 
blades and a pump speed generally ranging from 
8,000-12,000 revolutions per minute (rpm) [28]. 
Subject A’s LVAD had an operating speed of 
9,200 rpm pre-intervention and 9,400 rpm post-
pump exchange. Subject B was implanted with a 
HeartWare HVAD (HVAD; Medtronic, Inc., 
Minneapolis, MN) and had a stent inserted after a 
thrombus had narrowed the LVAD’s outflow graft 
and compromised blood flow from the device. The 
HVAD is a centrifugal pump with a wide-bladed 
rotor design with four blood flow channels. 
Recommended pump speeds are between 2,400-
3,200 rpm [29]. Subject B’s LVAD had an 
operating speed of 3,060 pre-intervention and 
3,100 rpm post-stenting. 
B.  Signal Processing  
1)  Pre-processing 
 The precordial sound recordings were 
collected at a sampling rate of 48,000 Hz. The 
recordings were first bandpass filtered between 
20-500 Hz to restrict the range of frequencies to 
the expected range of normal and abnormal heart 
sounds [30]. For computational simplicity and 
compatibility with the heart sound segmentation 
algorithm used in this pipeline [18], the recordings 
were then downsampled to 1,000 Hz. 
2)  Signal Source Separation 
While pre-processing removed high frequency 
components of the LVAD sounds, additional 
processing was needed to attenuate frequency 
components within the bandpass frequency range 
of 20-500 Hz. The frequency spectrum generated 
by an LVAD is dependent upon the pump’s 
rotational speed, which defines the fundamental 
frequency (revolutions per minute/60 Hz) of the 
pump. Frequency peaks can be expected at 
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multiples, or harmonics, of the pump’s rotational 
frequency and, in particular, at multiples of the 
blade-passing frequency, which is determined 
accordingly [31]: 
                          𝑓"# = 𝑏 × 𝑓 (1) 
where 𝑓"# refers to the blade-passing frequency; 𝑏 
refers to the number of blades or blood flow 
channels in the LVAD rotor; and 𝑓 refers to the 
pump’s fundamental frequency.  
An adaptive filter with a noise cancellation 
architecture [32] was used to isolate LVAD noise 
from heart sounds, or the PCG signal. To estimate 
the noisy signal component (𝑛) within a signal 
mixture (𝑠 + 𝑛), a noise reference signal (𝑛+,-) 
that is both correlated with the noise within the 
mixture and uncorrelated with the signal(s) of 
interest is required. The noise estimate 𝑛/ is 
substracted from the signal mixture to obtain a 
denoised signal,  ?̂? = (𝑠 + 𝑛) − 𝑛/. Through a 
closed-loop process, the filter weights are adapted 
iteratively to minimise this signal difference. A 
normalized least-mean-squares (nLMS) adaptive 
filter was used, with the filter weights updated 
accordingly [33]: 𝑤(𝑡 + 1) = 𝑤(𝑡) + ?̅?𝜀 + 𝑛+,-8(𝑡)𝑛+,-(𝑡) 𝜖(𝑡)𝑛+,-(𝑡) 
where 𝑤 is the filter weight vector; 𝑡 is the current 
time index;  ?̅? is the nominal step size; 𝑛+,- is the 
noise reference; 𝜖 = (𝑠 + 𝑛) − 𝑛/ refers to the 
difference between the filter output and the 
mixture of signals; and ε  is a small constant that 
prevents division by a very small number. 
Here, the input signal mixture is the recording 
of precordial sounds, the noise within the mixture 
is the LVAD-generated signal, and the output after 
adaptive filtering is assumed to be the intrinsic 
precordial sounds, or denoised PCG signal. A 
noise reference was generated with a mixture of 
sinusoids corresponding to the frequencies at the 
LVAD harmonics of interest falling below 500 Hz, 
as determined by (1). An nLMS filter with a length 
of 200 samples was implemented using a filter step 
size ?̅? experimentally tuned by assessing the 
attenuation of amplitudes at LVAD-specific 
frequencies in the denoised signal. 
3)  Signal Segmentation 
 Finally, a state-of-the-art heart sound 
segmentation algorithm developed by Springer et 
al., 2017 [18] was employed to segment the 
denoised PCG signals. The Springer et al., 2017 
algorithm is based on a hidden semi-Markov 
model (HSMM) that incorporates expected stage 
durations and logistic regression-based emission 
probabilities to determine the most likely sequence 
of stages after analyzing input features extracted 
from the signal. The input features include: the 
homomorphic envelogram; the Hilbert envelope; 
the wavelet envelope; and the power spectral 
density (PSD) envelope, which are calculated at a 
sampling frequency of 50 Hz [18]. The parameters 
of the HSMM were trained using a database of 
PCG signals collected from a non-LVAD 
population. Since a database of PCG signals 
obtained from the LVAD population is 
unavailable, this model was used with the 
assumption that the learned PCG signal model will 
translate across populations.  
C.  Post-segmentation Analysis 
Due to the lack of cardiac cycle labels for the 
denoised PCG data, the performance of the 
segmentation algorithm cannot be directly 
evaluated. Therefore, existing knowledge of heart 
sound characteristics was used to assess the 
validity of the cardiac cycle labels estimated by the 
segmentation algorithm. 
1)  Springer’s Segmentation Algorithm 
Features 
The features extracted by Springer’s 
segmentation algorithm were examined to assess 
the separability of the labelled cardiac cycle 
stages. For visualization, the features were 
averaged over each segmented cardiac cycle stage 
and the dimensionality of the averaged features 
was reduced to three dimensions using principal 
component analysis (PCA). 
2)  Cross-correlation 
The validity of the segmentation labels was also 
assessed by comparing similarities of signals 
within the same stage and between stages. We 
expect S1 and S2 signals to be more similar to 
themselves than to any other stage, and to be more 
similar to each other than to the generally quieter 
inter-FHS regions. The cross-correlation metric 
measures the similarity between two signals as a 
function of the delay of one relative to the other 
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and is calculated accordingly [34]: 𝑅;,=[𝑙] = 𝐸{𝑥[𝑡]𝑦∗[𝑡 − 𝑙]} 
where 𝑅;,=[𝑙] denotes the cross-correlation 
between two signals, 𝑥  and 𝑦 , at a lag 𝑙 of one 
signal relative to the other; 𝑡 is the time index; ∗ 
denotes the complex conjugate of a signal; and E{} 
denotes the expected value. The cross-correlation 
metric accounts for non-alignment and amplitude 
scale differences (via a normalized measure) 
between signal pairs. The maximum cross-
correlation between two signals G𝑅;,=HIJ	L across 
times lags was determined for each signal pair. The 
average maximum within-stage and between-stage 
cross-correlations were computed based on 
pairings of signals of the same stage and across 
two stages, respectively. 
3) Power Spectral Density Estimation 
Frequency representations of the signals were 
obtained to assess the removal of LVAD 
harmonics of interest after adaptive filtering and 
compare the frequency characteristics of the 
segmented signals with expected heart sound 
characteristics. A periodogram was used to 
estimate the power spectral density (PSD) of a 
signal against frequency accordingly [34]: 𝑃;N G𝑒PQL = 1𝑁 S𝑋G𝑒PQLSU 
where 𝜔 is the angular frequency;  𝑃;N G𝑒PQL is the 
power spectral density estimate; 𝑋G𝑒PQL is the 
Fourier transform of the signal; and	𝑁 is the signal 
length in samples. 
Welch’s windowing and averaging method, 
which reduces the variance of the estimated PSD, 
was used to compute the PSD estimates [35]. The 
Hann function was used for windowing: when the 
entire PCG signal was processed, a window length 
of 0.2s and window overlap of 50% were used to 
deliver an appropriate frequency resolution; when 
individual cardiac cycle stages were processed, a 
window length of 75% of the signal length, 
selected due to the small overall signal length, and 
an overlap of 50%, were used.  
4)  Continuous Wavelet Transform 
Time-frequency representations of the denoised 
PCG signals were obtained to describe  changes in 
the signals’ frequency content over time, enabling 
comparisons between the characteristics of these 
signals and known characteristics of heart sounds. 
A one-dimensional (1-D) continuous wavelet 
transform (CWT) performed with the transform 
calculated accordingly [36]: 𝛾(𝑠, 𝜏) = Y𝑓(𝑡)𝜓[,\∗ (𝑡)𝑑𝑡 
where 𝛾(𝑠, 𝜏) is the continuous wavelet transform; 𝑓(𝑡) is the original signal that is decomposed into 
a set of basis functions s; 𝜓(𝑡) generated from a 
mother wavelet; ∗ denotes the complex conjugate; 
and 𝑠 and 𝜏 denote the scaling and translation of 
the mother wavelet, respectively. The Morlet 
wavelet was used [37] due to its similarity to the 
fundamental heart sounds [38, 39] and its ability to 
provide a reliable time-frequency representation 
for PCG signal analysis [40]. 
 
RESULTS 
Each subject’s precordial sound recordings 
were processed and segmented using the signal 
processing pipeline previously described above, 
with Figure 1 showing the effect of filtering on the 
post-intervention recordings. The PSD estimates 
of the raw signals for Subjects A and B, shown in 
Figure 1c and g, respectively, indicate peaks at the 
pump harmonics. After adaptive filtering, pump-
specific frequencies are notably attenuated, and the 
majority of the signal power in each denoised post-
intervention PCG is below 200 Hz, which is 
consistent with the expected range of heart sounds. 
The impact of adaptive filtering is more salient in 
Subject B’s recordings (Figure 1g and h), likely 
due to the lower LVAD rotational frequency 
resulting in more noise below 500 Hz. 
Figure 1d and h show the magnitude 
scalograms of the CWT of the denoised PCG 
signals for Subjects A and B, respectively. In 
general, there is more energy in the labelled FHS 
segments than in inter-FHS regions (systole and 
diastole. In Subject A’s signals, there appears to be 
some high frequency activity in the inter-FHS 
regions, which may be attributed to breath sounds 
or regurgitation sounds. Also, labelled S2 
segments in Subject A are relatively muted, 
potentially indicative of intermittent or absent S2, 
which is consistent with enhanced left ventricular 
unloading after dysfunctional LVAD exchange  
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Figure 1. Time- and frequency-domain representations of post-intervention signals collected from Subjects A (top panel) and 
B (bottom panel). (a, e) Raw time-domain PCG (b, f): Filtered time-domain PCG signal with superimposed labels. (c, g): Power 
spectral density (PSD) estimates of raw and filtered recording, with the LVAD harmonic frequencies noted; (d, h): Magnitude 
scalogram contour of the continuous wavelet transform (CWT) of the PCG signal post-adaptive filtering. 
based on anecdotal information from clinical 
experts. Overall, adaptive filtering removed 
LVAD noise and improved the SNR of the PCG 
signals with minimal impact on heart sounds. 
The performance of the segmentation algorithm 
was assessed qualitatively by analyzing temporal 
and spectral characteristics of the labelled cardiac 
cycle stages. Figure 2a-b and 2e-f show the PCA 
visualization of the features extracted by 
Springer’s segmentation algorithm from the 
denoised PCG signals for Subject A. For Subject 
A, the features from labelled S1 segments have 
distinct clusters, while the labelled S2 segments 
cluster together with the labelled inter-FHS 
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segments (Figure 2a-b). This suggests that Subject 
A’s labelled S2 sounds are similar to labelled inter-
FHS segments, in accordance with the previous 
observation of muted S2 sounds (see Figure 1a-b). 
In contrast, in Subject B’s PCA visualization, 
labelled FHS segments cluster distinctly from 
labelled inter-FHS segments (Figure 2e-f). The 
averaged maximum cross-correlations of the 
temporal profiles of cardiac cycle stage segments 
for Subjects A and B are shown in Figure 2c-d and 
g-h, respectively. For each subject, the highest 
within-stage correlations are observed for FHS 
segment pairs (S1-S1 and S2-S2), followed by 
between-stage correlation of FHS segment pairs 
(S1-S2), except for cross-correlations of labelled 
pre-intervention S2 segments for Subject A. 
Analyses of PCA clusters and cross-correlation 
suggest that labelled FHSs are distinct from the 
inter-FHS regions (except for Subject A’s labelled 
S2 segments) and from each other, and labelled 
inter-FHS segments generally exhibit lower 
within- and between-stage correlations. For 
Subject A’s post-intervention signals, while 
features from labelled S2 segments cluster with 
inter-FHS segments (Figure 2b), the temporal 
profiles of S2-S2 segment pairs are noticeably 
higher than S2-inter-FHS segment pairs (Figure 
2d). This finding suggests that alternative signal 
representations are needed to better characterize 
and reveal differences between cardiac cycle stage 
segments. 
Knowledge of the expected amplitude and 
frequency characteristics of the FHS and inter-
FHS regions was leveraged to inform our 
assessment of the validity of the segmentation 
algorithm. The PSD estimates of the cardiac cycle 
stage segments for Subject A and B are shown in 
Figure 3a and b, respectively. Except for the muted 
S2 sounds in Subject A, labelled inter-FHS 
segments (systole and diastole) are much lower in 
amplitude than the FHSs in each subject’s 
recordings, which matches expectations that the 
FHSs are the dominant sounds in PCGs. The 
relatively low amplitudes of labelled S2 sounds in 
Subject A again indicate faint or absent S2 sounds 
(Figure 3a).  For Subject B, three attributes of the 
labelled FHSs in Figure 3b strongly suggest 
accurate segmentation. First, the dominant 
frequencies of labelled S2 sounds are higher than 
those of labelled S1 sounds [11, 23]. Next, the 
frequency ranges of the labelled S2 segments are 
broader than those of the labelled S1 segments 
[22]. Finally, the amplitudes of labelled S2 sounds 
are higher than those of labelled S1 sounds, which 
is generally expected from recordings made at the 
left upper sternal border [13]. 
 
 
 
Figure 2. Principal component analysis (PCA) and average 
maximum cross-correlation representations of cardiac cycle 
stage segments obtained from pre- and post-intervention 
PCG signals of Subjects A (left panel) and B (right panel). In 
each panel, the top row shows the 3D principal component 
representations of Springer segmentation algorithm features 
for pre-intervention (a, e) and post-intervention (b, f) signals, 
labelled by assigned cardiac cycle stage; and the bottom row 
shows the average maximum cross-correlation values within- 
and between- cardiac stages for pre-intervention (c, g) and 
post-intervention (d, h) signals. Higher cross-correlation 
values indicate greater similarity between stages.
(a) (b) 
(c) (d) 
(e) (f) 
(g) (h) 
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Figure 3. Power spectral density estimates of labelled cardiac cycle stage segments in pre- and post-intervention PCG 
signals from (a) Subject A and (b) Subject B. 
 
 
CONCLUSIONS 
This work developed and evaluated a signal 
processing pipeline to extract and analyze heart 
sounds in LVAD-supported individuals. 
Precordial sounds were pre-processed and 
adaptive filtering applied to attenuate LVAD-
specific frequencies and enhance underlying heart 
sounds. A state-of-the-art segmentation algorithm 
was used to identify and label the cardiac cycle 
stages within the denoised PCG signals. While the 
performance of the segmentation algorithm could 
not be directly evaluated due to the absence of 
ground truth labels, various time and frequency 
analysis techniques were employed to assess the 
validity of the algorithm’s cardiac cycle label 
outputs. In general, the fundamental heart sounds 
(S1 and, where present, S2) could be distinguished 
from the inter-FHS regions (systole and diastole), 
and the time-frequency characteristics of the FHS 
segments generally showed agreement with 
(a) 
(b) 
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published characteristics. 
Acoustic analysis has the potential to be a 
relatively low-cost diagnostic tool for remote and 
real-time monitoring of heart function in LVAD-
supported individuals.  While the work presented 
here utilized a limited amount of data, this is, to 
our knowledge, the first preliminary evidence of 
the feasibility of automated heart sound analysis in 
LVAD-supported individuals.  Our algorithm 
development and analysis relied on leveraging 
prior work on heart sound analysis in individuals 
without LVAD support, with the assumption that 
heart sound characteristics are similar across 
individuals with and without LVAD support. 
However, this assumption might not necessarily 
provide the best context for analyzing the potential 
diversity of heart sounds that can be observed in 
the population of LVAD-supported individuals, as 
is demonstrated by the between-subject 
variabilities observed in this study. In addition, the 
presence of other physiological sounds, e.g., lung 
sounds and sounds that can be generated due to 
pump-heart interactions, may impact algorithm 
performance. Future work includes developing a 
repository of precordial sounds from individuals 
with LVADs to develop more robust signal 
processing algorithms and better characterize 
acoustic signatures of heart sounds in the 
population of LVAD-supported individuals. 
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